Wall Street's consensus price target of $110 implies more than 220% upside to Viking stock. Wall Street has high hopes for development-stage pharmaceutical company Viking Therapeutics. Medications ...

The $55 price target for Viking Holdings represents a 10% near-term upside, implying that the analysts see potential for the stock to rise in value shortly. Loop Capital's evaluation is based on ...

Viking Cruises, Royal Caribbean receive price hikes as cruise booking demand remains strong. VIK breaks out, cruise lines retake key averages. As the U.S. stock market reacts positively to benign ...

Is that price target realistic? Should you buy Viking Therapeutics stock before it goes to the moon? Wall Street is bullish on Viking, but the company still has a lot to prove Viking has a number ...

Similar read-outs, the option market and current valuation of VKTX of $3.64 Bn imply huge stock price upside to ... Click here to find out more » Viking Therapeutics (NASDAQ:VKTX) is a clinical ...